北美血液过滤器市场预测至 2028 年 - COVID-19 影响和按产品（40 微米和 70 微米、100 微米和 170 微米等）、材料（聚碳酸酯、聚酯、ABS 等）、应用（血液）进行区域分析处理和输血）和最终用户（血库、医院等）
No. of Pages: 118 | Report Code: TIPRE00027051 | Category: Life Sciences
No. of Pages: 118 | Report Code: TIPRE00027051 | Category: Life Sciences
人口老龄化和生活方式的变化正在导致慢性病患病率稳步上升。快速增长的中产阶级人口和城市化正在推动久坐生活方式的采用。设施的现代化减少了人们的体力活动，而各种个人、职业和社会因素则增加了人们的压力水平。关节炎;心血管疾病，例如心脏病发作和中风；乳腺癌和结肠癌；糖尿病;癫痫和惊厥；肥胖;口腔健康问题是发达国家老年人报告的主要慢性病之一。慢性病影响着各国的公共卫生、社会和经济。血液过滤器广泛用于各种外科手术，例如心脏手术和其他侵入性手术。癌症、心血管疾病和肾脏疾病等慢性疾病是全世界人类死亡的主要原因。这些病症通常通过外科手术治疗，这可能会导致失血过多。因此，这些程序之后是向患者输注新鲜血液或回输他们自己的血液。在输血或回输过程中使用血液过滤器。因此，北美血液过滤器市场随着慢性病负担的迅速增加而不断增长。
COVID-19中发生的细胞因子风暴患者会造成严重的器官损伤，如果病情恶化，可能会导致患者死亡。在美国，当患者表现出不适时，医生首次将肾透析机上的常用过滤器替换为捕获这些微小蛋白质以避免破坏的过滤器。批准的产品减少了细胞因子和其他炎症介质的数量，即血液中的小活性蛋白质，通过过滤血液并将过滤后的血液返回患者体内来控制细胞的免疫反应。 ABO 血型特征反映了 ABO 基因内的多态性。该基因与其他几个特征相关，包括 COVID-19 发病和死亡风险因素。例如，全基因组关联研究发现 ABO 内的变异与血管紧张素转换酶活性、红细胞计数、血细胞比容、血红蛋白浓度、血管性血友病因子、心肌梗死、缺血性中风、2 型糖尿病、冠状动脉疾病和静脉血栓栓塞有关。这些条件也与 COVID-19 相关。由于社会限制以及疫情爆发初期存在疾病传播的可能性，北美国家的献血人数大幅减少。在大流行的早期阶段，华盛顿和美国其他地区的血液供应出现暂时大幅下降。医院和无偿献血中心积极落实血液保护策略，努力鼓励无偿献血。血液保护计划可能导致输血量减少。 2020 年初，医院取消或推迟了优先考虑 COVID-19 患者的择期手术，也导致血液需求量显着减少。
到 2028 年北美血液过滤器市场收入及预测（千美元）
< /p>
< h3>
·
·Strategic insights for North America Blood Filter involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,56,782.04 thousand |
| Market Size by 2028 | US$ 2,09,486.60 thousand |
| Global CAGR (2021 - 2028) | 4.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Blood Filter refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Blood Filter Market is valued at US$ 1,56,782.04 thousand in 2021, it is projected to reach US$ 2,09,486.60 thousand by 2028.
As per our report North America Blood Filter Market, the market size is valued at US$ 1,56,782.04 thousand in 2021, projecting it to reach US$ 2,09,486.60 thousand by 2028. This translates to a CAGR of approximately 4.2% during the forecast period.
The North America Blood Filter Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Blood Filter Market report:
The North America Blood Filter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Blood Filter Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Blood Filter Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Blood Filter Market
